Improved Aequorin for Ca Assay in Functioning Cells
改进的水母发光蛋白用于功能细胞中 Ca 的测定
基本信息
- 批准号:8801148
- 负责人:
- 金额:$ 24.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Continuing Grant
- 财政年份:1988
- 资助国家:美国
- 起止时间:1988-08-01 至 1992-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The photoprotein aequorin (initially isolated by the P.I. in 1962) has been widely used as a Ca -indicator in living cells. However, the preparations of aequorin used in the past were undefinable mixtures of isoaequorins containing impurities. Recently, two improved types of aequorin were prepared in the P.I.'s laboratory: the first is pure isoaequorins consisting of single molecular species, and the second is a semi-synthetic photoprotein designated e-aequorin in which the functional group is modified. The luminescence spectrum of e-aequorin shows two peaks (405 nm and 465 nm) and the ratio of the peak intensities is ıCa !-dependent in the pCa range of 5 - 7, thus allowing the determination of Ca concentration directly from the intensity ratio of the two peaks. The primary objective of this project is to establish the advantage of using isoaequorins and e-aequorin in measuring intracellular Ca , compared with other Ca -indicators; this will be accomplished by the actual use of those materials by collaborating cell biologists. Sufficient amounts of isoaequorins and e-aeqourin will be produced for this purpose and also to comply with requests from other investigators. To increase the yields of more useful types of isoaequorins, interconversion between isoaequorins will be investigated. The second objective is to prepare other useful forms of semi- synthetic aequorin which excel isoaequorins and e-aequorin; this will be done by further modification of the functional group.
发光蛋白水母发光蛋白(最初由P.I.在 1962)已被广泛用作活细胞中的Ca -指示剂。 然而,过去使用的水母发光蛋白制剂 含有杂质的不确定的异水母发光蛋白混合物。 最近,我们制备了两种改进型水母发光蛋白 P.I.的实验室:第一种是纯异水母发光蛋白, 第一种是单分子物种,第二种是半合成的 称为e-水母发光蛋白的光蛋白,其中官能团 被修改了。 e-aequorin的发光光谱显示两个 峰(405 nm和465 nm)和峰强度的比值 是卡!-依赖于5 - 7的pCa范围,从而允许 测定钙 浓度直接从强度 两个峰值的比值。 该项目的主要目标是建立 在测量中使用异水母发光蛋白和e-水母发光蛋白的优点 细胞内钙,与其他钙指标相比;这 将通过实际使用这些材料来实现, 合作的细胞生物学家 足够量的 将为此目的生产异水母发光蛋白和e-水母发光蛋白 并遵守其他调查人员的要求。 到 增加更有用类型的异水母发光蛋白的产率, 将研究异水母发光蛋白之间的相互转化。 的 第二个目的是制备其它有用形式的半- 合成水母发光蛋白,其优于异水母发光蛋白和e-水母发光蛋白;该 将通过进一步修饰官能团来完成。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Osamu Shimomura其他文献
Glycan expression profile of signet gastric cancer and potential applicability of lectin drug conjugate
印戒胃癌的聚糖表达谱和凝集素药物缀合物的潜在应用
- DOI:
- 发表时间:
2022 - 期刊:
- 影响因子:0
- 作者:
Yoshimsa Akashi;Yu Yang;Osamu Shimomura;Yoshihiro Miyazaki;Tatsuya Oda;et al. - 通讯作者:
et al.
Evaluation of the risk of diarrhea induced by epidermal growth factor receptor tyrosine kinase inhibitors with cultured intestinal stem cells originated from crypts in humans and monkeys.
使用源自人类和猴子隐窝的培养肠干细胞评估表皮生长因子受体酪氨酸激酶抑制剂诱发腹泻的风险。
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:3.2
- 作者:
Yoshiki Hashimoto;K. Maeda;Osamu Shimomura;Yoshihiro Miyazaki;S. Hashimoto;Akiko Moriyama;Tatsuya Oda;H. Kusuhara - 通讯作者:
H. Kusuhara
Pancreatic juice out ow in pancreatojejunostomy monitoring with the inter-anastomosis drainage tube; a retrospective observational study
胰肠吻合术中吻合引流管监测胰液流出情况
- DOI:
- 发表时间:
2022 - 期刊:
- 影响因子:0
- 作者:
Osamu Shimomura;Yoshihiro Miyazaki - 通讯作者:
Yoshihiro Miyazaki
Novel therapeutic strategy for pancreatic cancer with lectin drug conjugate (LDC) ~ the Efficacy and pilot Safety test~
凝集素药物结合物(LDC)治疗胰腺癌的新策略〜功效和先导安全性测试〜
- DOI:
- 发表时间:
2018 - 期刊:
- 影响因子:0
- 作者:
Osamu Shimomura;Tatsuya Oda;Hiroaki Tateno;Yusuke Ozawa;Sota Kimura;Shigo Sakashita;Jun Hirabayashi;Masayuki Noguchi;Makoto Asashima;Nobuhiro Ohkohchi - 通讯作者:
Nobuhiro Ohkohchi
Osamu Shimomura的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Osamu Shimomura', 18)}}的其他基金
The detection of early stage pancreatic cancer with sandwich ELISA using tumor specific lectins
使用肿瘤特异性凝集素通过夹心 ELISA 检测早期胰腺癌
- 批准号:
18K16298 - 财政年份:2018
- 资助金额:
$ 24.06万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Improved Aequorin for Monitoring Ca and Superoxide in Cells
改进的水母发光蛋白用于监测细胞中的钙和超氧化物
- 批准号:
9722982 - 财政年份:1997
- 资助金额:
$ 24.06万 - 项目类别:
Continuing Grant
Improved Aequorin for Ca Assay in Functioning Cells
改进的水母发光蛋白用于功能细胞中 Ca 的测定
- 批准号:
9403183 - 财政年份:1994
- 资助金额:
$ 24.06万 - 项目类别:
Continuing Grant
Improved Aequorin for Ca Assay in Functioning Cells
改进的水母发光蛋白用于功能细胞中 Ca 的测定
- 批准号:
9101712 - 财政年份:1991
- 资助金额:
$ 24.06万 - 项目类别:
Continuing Grant
相似海外基金
Aequorin-based Functional Assays for HTS of tyrosine Kinases and Other Cell Surface Receptor Modulators
基于水母发光蛋白的酪氨酸激酶和其他细胞表面受体调节剂 HTS 功能测定
- 批准号:
371306-2008 - 财政年份:2011
- 资助金额:
$ 24.06万 - 项目类别:
Industrial Research Fellowships
Aequorin-based Functional Assays for HTS of tyrosine Kinases and Other Cell Surface Receptor Modulators
基于水母发光蛋白的酪氨酸激酶和其他细胞表面受体调节剂 HTS 功能测定
- 批准号:
371306-2008 - 财政年份:2010
- 资助金额:
$ 24.06万 - 项目类别:
Industrial Research Fellowships
Aequorin-based Functional Assays for HTS of tyrosine Kinases and Other Cell Surface Receptor Modulators
基于水母发光蛋白的酪氨酸激酶和其他细胞表面受体调节剂 HTS 功能测定
- 批准号:
371306-2008 - 财政年份:2009
- 资助金额:
$ 24.06万 - 项目类别:
Industrial Research Fellowships
Beyond GFP and aequorin: Ocean-wide study of fluorescent and luminous proteins
超越 GFP 和水母发光蛋白:荧光和发光蛋白的全海洋研究
- 批准号:
7496415 - 财政年份:2006
- 资助金额:
$ 24.06万 - 项目类别:
Beyond GFP and aequorin: Ocean-wide study of fluorescent and luminous proteins
超越 GFP 和水母发光蛋白:荧光和发光蛋白的全海洋研究
- 批准号:
7133657 - 财政年份:2006
- 资助金额:
$ 24.06万 - 项目类别:
Beyond GFP and aequorin: Ocean-wide study of fluorescent and luminous proteins
超越 GFP 和水母发光蛋白:荧光和发光蛋白的全海洋研究
- 批准号:
7283149 - 财政年份:2006
- 资助金额:
$ 24.06万 - 项目类别:
Beyond GFP and aequorin: Ocean-wide study of fluorescent and luminous proteins
超越 GFP 和水母发光蛋白:荧光和发光蛋白的全海洋研究
- 批准号:
7681463 - 财政年份:2006
- 资助金额:
$ 24.06万 - 项目类别:
Highly sensitive and rapid tandem bioluminescent immunoassay using aequorin labeled Fab fragment and biotinylated firefly luciferase
使用水母发光蛋白标记的 Fab 片段和生物素化的萤火虫荧光素酶进行高灵敏度和快速串联生物发光免疫分析
- 批准号:
17590039 - 财政年份:2005
- 资助金额:
$ 24.06万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Production of new recombinant aequorin and its physiological application
新型重组水母发光蛋白的制备及其生理应用
- 批准号:
13557004 - 财政年份:2001
- 资助金额:
$ 24.06万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




